T

Teva Pharmaceutical Industries Limited

TEVA

17.530
USD
0.1
(0.57%)
Market Closed
Volume
120,956
EPS
0
Div Yield
0
P/E
-47
Market Cap
20,822,864,920
Related Instruments
AMGN
2.78
(0.84%)
335.22 USD
BMY
0.620
(1.30%)
48.180 USD
GSK
0.865
(2.23%)
39.650 USD
LLY
28.47
(3.54%)
832.74 USD
M
MNK
-0.06490
(-16.07%)
0.33900 USD
NVS
0.650
(0.58%)
112.100 USD
PFE
0.115
(0.38%)
30.650 USD
P
PRGO
-0.125
(-0.44%)
28.140 USD
News

Title: Teva Pharmaceutical Industries Limited

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.